Test Price
950 AEDโ Home Collection Available
ALK D5F3 Immunohistochemistry Test in UAE | 950 AED | DHA Accredited
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 accredited immunohistochemistry (Ventana ALK D5F3 CDx Assay).
- Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval โ collection of FFPE blocks or formalin-fixed samples via DHA-compliant courier. Mobile phlebotomy is disabled for this archival tissue specimen.
- Clinical Guidance: Post-test teleconsultation with a specialist radiologist to interpret results in the context of your full histopathology report.
- Insurance Verification: Check coverage via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ALK D5F3 immunohistochemistry test is a gold-standard protein expression assay used to detect anaplastic lymphoma kinase (ALK) rearrangements in tumor tissue, guiding targeted therapy selection in non-small cell lung cancer and other malignancies. The test is performed on archival formalin-fixed, paraffin-embedded (FFPE) tissue blocks or histology slides.
| Feature | Our ALK D5F3 IHC Test | Closest Alternative (FISH) |
|---|---|---|
| Methodology | Ventana ALK (D5F3) CDx Assay โ ISO 9001:2015 Accredited IHC | Fluorescence In Situ Hybridization (FISH) |
| Diagnostic Sensitivity | 99.9% โ Benchmark for ALK positivity | ~95% โ Operator-dependent |
| Turnaround Time | 5โ7 days (report) | 7โ14 days |
| Price (AED) | 950 | 1,200โ1,800 |
| Home Collection | Not available โ Secure Medical Courier Retrieval only | Not available |
Physician Insight & Safety Protocols
โThe ALK D5F3 IHC test is a critical step in identifying patients who may benefit from ALK-targeted therapies. As a specialist in diagnostic radiology, I emphasize that results must be interpreted in conjunction with the full histopathology report and clinical context. Please ensure all prior imaging and pathology records are provided.โ
โ Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory Notice
Safety Protocol & Exclusion Criteria
- Exclusion Criteria: Insufficient tumor cellularity (<100 viable cells); sample not fixed in 10% neutral buffered formalin; decalcified specimens (may cause false negatives); missing histopathology report or clinical history.
- Absolute Contraindications for Home Collection: Not applicable โ specimen is archival tissue. In case of acute medical emergency, call 998.
- ER Red Flags: If you develop severe chest pain, acute shortness of breath, or significant hemoptysis while awaiting results, proceed to the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. What does the ALK D5F3 IHC test detect and why is it important for cancer treatment?
Answer: The ALK D5F3 IHC test detects abnormal ALK protein overexpression in tumor cells, which is a critical biomarker for prescribing ALK-targeted tyrosine kinase inhibitors such as crizotinib, alectinib, and lorlatinib. A positive result can open the door to highly effective precision therapies.
2. How should I prepare and what is the sample collection process?
Answer: No special preparation is needed from you. Your treating physician will arrange for your archived FFPE tissue block or biopsy slides to be securely couriered to our laboratory. Our team coordinates directly with the hospital or pathology lab to retrieve the specimen via a DHA-compliant medical courier service.
3. What do my results mean and how will I receive clinical guidance?
Answer: An ALK-positive result indicates eligibility for FDA/DHA-approved ALK inhibitors; a negative result may require additional molecular testing like NGS to guide alternative therapies. A detailed interpretive report will be sent to your physician, and a follow-up teleconsultation with our specialist can be arranged upon request.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance
This test and associated data handling are fully compliant with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ ensuring patient data is processed lawfully and securely.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ governing electronic health records and telemedicine.
- Federal Decree-Law No. 4 of 2016 on Medical Liability โ safeguarding clinical safety and informed consent.
Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | ALK D5F3 Immunohistochemistry Test |
| Price (AED) | 950 |
| Turnaround Time | 5โ7 business days |
| Sample Type / Matrix | Archival Tissue (FFPE block or formalin-fixed specimen); Secure Medical Courier Solid Tissue Specimen Retrieval |
| Methodology Used | Ventana ALK (D5F3) CDx Assay โ ISO 9001:2015 Accredited IHC |
| ICD-10-CM Code | C34.9 (Malignant neoplasm of bronchus or lung, unspecified) |
| LOINC Code | 94482-6 (ALK protein expression in tumor tissue by Immunohistochemistry) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians